GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergan PLC (FRA:A60) » Definitions » LT-Debt-to-Total-Asset

Allergan (FRA:A60) LT-Debt-to-Total-Asset : 0.20 (As of Mar. 2020)


View and export this data going back to 2015. Start your Free Trial

What is Allergan LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Allergan's long-term debt to total assests ratio for the quarter that ended in Mar. 2020 was 0.20.

Allergan's long-term debt to total assets ratio stayed the same from Mar. 2019 (0.20) to Mar. 2020 (0.20).


Allergan LT-Debt-to-Total-Asset Historical Data

The historical data trend for Allergan's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergan LT-Debt-to-Total-Asset Chart

Allergan Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
LT-Debt-to-Total-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.30 0.23 0.22 0.23 0.20

Allergan Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
LT-Debt-to-Total-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.20 0.21 0.20 0.20 0.20

Allergan LT-Debt-to-Total-Asset Calculation

Allergan's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2019 is calculated as

LT Debt to Total Assets (A: Dec. 2019 )=Long-Term Debt & Capital Lease Obligation (A: Dec. 2019 )/Total Assets (A: Dec. 2019 )
=16706.34/85229.19
=0.20

Allergan's Long-Term Debt to Total Asset Ratio for the quarter that ended in Mar. 2020 is calculated as

LT Debt to Total Assets (Q: Mar. 2020 )=Long-Term Debt & Capital Lease Obligation (Q: Mar. 2020 )/Total Assets (Q: Mar. 2020 )
=16323.756/80025.711
=0.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Allergan  (FRA:A60) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.


Allergan LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Allergan's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergan (FRA:A60) Business Description

Traded in Other Exchanges
N/A
Address
Clonshaugh Business and Technology Park, Coolock, Dublin, IRL, D17E400
Allergan PLC is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. The products offered by the company include Botox, Celexa, Fetzima, Refresh, Ozurdex and Zenpep among others.

Allergan (FRA:A60) Headlines

No Headlines